Free Calculator

eSampling ROI Calculator

Compare eSampling vs physical sampling ROI for pharmaceutical products. Calculate cost savings, sample-to-script conversion rates, and PDMA compliance cost impact with side-by-side analysis.

How eSampling ROI Is Calculated

eSampling ROI compares the total cost of digital sample fulfillment against traditional physical sampling, factoring in distribution costs, compliance overhead, field rep time, and downstream script conversion revenue.

Physical Sampling Cost
Samples x Cost Per Sample + Compliance + Rep Distribution Overhead
eSampling Cost
Samples x Cost Per eSample + (Reduced Compliance Cost)
Sample-to-Script Rate
New Scripts Generated / Total Samples Distributed x 100%
Sampling ROI
(Revenue from Converted Scripts - Total Sampling Cost) / Total Sampling Cost x 100%

Enter Sampling Program Data

Enter your sampling metrics to compare physical vs eSampling costs, ROI, and script conversion economics.

Manufacturing + packaging + distribution
Digital fulfillment cost
Tracking, auditing, storage costs

eSampling ROI Results

Physical Sampling Total Cost
Monthly all-in cost
eSampling Total Cost
Monthly all-in cost
Cost Savings with eSampling
Monthly savings vs physical
Total New Scripts Generated
Monthly converted scripts
Revenue from Converted Scripts
Annualized revenue
Physical Sampling ROI
Annual return on sampling investment
eSampling ROI
Annual return on eSampling investment
Cost Per Conversion
Physical vs eSampling

Physical vs eSampling Comparison

Metric Physical Sampling eSampling Difference
Cost Per Sample
Monthly Distribution Cost
PDMA Compliance Cost
Total Monthly Cost
Scripts Generated (Monthly)
Cost Per Conversion
Annual ROI

Industry Benchmarks by Specialty

Physical Sample Cost $10 - $25
Avg manufacturing + packaging + distribution
eSample Cost $2 - $5
Digital fulfillment + pharmacy activation
Primary Care Conversion 5 - 8%
Sample-to-script for primary care brands
Specialty Conversion 8 - 12%
Sample-to-script for specialty therapeutics

Sampling Strategy Recommendations

Download Sampling Strategy Comparison Template

Get the full template to compare physical vs eSampling programs, model conversion economics, and build a PDMA-compliant sampling strategy business case.

eSampling vs Physical Sampling: A Complete ROI Guide

Pharmaceutical sampling remains one of the most effective strategies for driving new-to-brand prescriptions. However, the economics of traditional physical sampling — manufacturing, cold-chain logistics, field rep distribution time, and PDMA compliance overhead — are prompting many pharma companies to shift toward eSampling (electronic sampling) programs. Understanding the ROI of each approach is critical for optimizing your sampling investment.

What is eSampling?

eSampling, also known as electronic sampling or digital sampling, allows HCPs to request product samples through a digital platform — typically during or after a rep visit, or through a self-service portal. Instead of carrying physical inventory, reps trigger a digital fulfillment process that ships samples directly to the HCP's office or activates a pharmacy voucher for the patient. This eliminates manufacturing waste, reduces storage costs, and streamlines PDMA compliance tracking.

Key Sampling Metrics Explained

Sample-to-Script Conversion Rate

The percentage of distributed samples that result in a new prescription. Industry benchmarks range from 5-8% for primary care brands and 8-12% for specialty therapeutics. eSampling programs often see 10-20% higher conversion rates than physical sampling because digital tracking enables better follow-up and targeting.

Cost Per Sample (Physical vs Digital)

Physical sample costs include manufacturing, packaging, cold-chain shipping, warehouse storage, field rep distribution time, and sample closet management at HCP offices. These typically range from $10-$25 per unit. eSampling costs — covering digital platform fees, pharmacy activation, and fulfillment — typically range from $2-$5 per unit, representing a 70-85% cost reduction.

PDMA Compliance

The Prescription Drug Marketing Act (PDMA) requires pharmaceutical companies to maintain detailed tracking of all sample distribution — from manufacturer to HCP office. Physical sampling requires manual reconciliation, closet audits, and paper-based tracking. eSampling platforms automate PDMA compliance with digital audit trails, reducing compliance costs by 40-60% and virtually eliminating reconciliation errors.

Field Rep Time Savings

Physical sample management consumes significant field rep time — inventory management, closet organization, sample reconciliation, and carrying physical product to calls. Studies show reps spend 15-25% of their time on sample logistics. eSampling eliminates this overhead, freeing reps to spend more time on clinical discussions and relationship building.

eSampling ROI Calculator FAQ

What is a good sample-to-script conversion rate?

A good conversion rate depends on therapeutic area. Primary care brands typically see 5-8% conversion, while specialty products achieve 8-12%. eSampling programs with targeted follow-up sequences can push conversion rates 10-20% above these benchmarks due to better data capture and HCP engagement tracking.

How does eSampling improve PDMA compliance?

eSampling platforms create an automatic digital audit trail for every sample request, fulfillment, and delivery. This eliminates manual reconciliation, reduces human error in sample tracking, and provides real-time visibility into sample inventory across the entire organization. Most eSampling platforms include built-in PDMA reporting, reducing audit preparation time from weeks to minutes.

Should I replace physical sampling entirely with eSampling?

Most pharmaceutical companies benefit from a hybrid approach. Physical samples remain valuable for initial product launches, high-value HCP targets, and therapeutic areas where hands-on product experience matters. eSampling excels for maintenance sampling, no-see physicians, remote territories, and scaling reach beyond the field force. The optimal mix varies by brand lifecycle stage and HCP segment.